Evidence map›Paper›PMID 32064269›Full record

ArticleFrontiers in veterinary science2019

Magnetic Nanotrap Particles Preserve the Stability of Venezuelan Equine Encephalitis Virus in Blood for Laboratory Detection.

Ivan Akhrymuk, Shih-Chao Lin, Mei Sun, Anurag Patnaik, Caitlin Lehman, Louis Altamura, Timothy Minogue, Ben Lepene, Monique L van Hoek, Kylene Kehn-Hall

Open access · goldAbstract read
In one paragraph

Article in Frontiers in veterinary science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Nanotechnology-based antiviral therapeutics.Drug delivery and translational research · 2021
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ivan AkhrymukNational Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA, United States.
Shih-Chao LinNational Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA, United States.
Mei SunUnited States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, United States.
Anurag PatnaikCeres Nanosciences, Inc., Manassas, VA, United States.
Caitlin LehmanNational Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA, United States.
Louis AltamuraUnited States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, United States.
Timothy MinogueUnited States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, United States.
Ben LepeneCeres Nanosciences, Inc., Manassas, VA, United States.
Monique L van HoekNational Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA, United States.
Kylene Kehn-HallNational Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA, United States.
George Mason University · USUnited States Army Medical Research Institute of Infectious Diseases · USCeres Nanosciences · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most of the modern techniques used for identification of viral-induced disease are based on identification of viral antigens and/or nucleic acids in patient's blood. Diagnosis in the field or in remote locations can be challenging and alternatively samples are shipped to diagnostic labs for testing. Shipments must occur under controlled temperature conditions to prevent loss of sample integrity. We have tested the ability of magnetic Nanotrap® (NT) particles to improve stability and detection of Venezuelan equine encephalitis virus (VEEV), viral capsid protein, and viral genomic RNA in whole human blood at elevated temperature and prolonged storage conditions. NT particles have previously been shown to capture and enrich multiple pathogens including respiratory syncytial virus, influenza virus, coronavirus, and Rift Valley fever virus. Our study indicates that samples incubated with NT particles had detectable levels of infectious VEEV in blood equal to or greater than samples without NT treatment across all temperatures. Viral RNA detection was increased in the presence of NT particles at later time points (72 h) and higher temperature (40°C) conditions. Likewise, detection of VEEV capsid protein was enhanced in the presence of NT particles up to 72 h at 40°C. Finally, we intranasally infected C3H mice with TC-83, the live attenuated vaccine strain of VEEV, and demonstrated that NT particles could substantially increase the detection of VEEV capsid in infected blood incubated up to 72 h at 40°C. Samples without NT particles had undetectable capsid protein levels. Taken together, our data demonstrate the ability of NT particles to preserve and enable detection of VEEV in human and mouse blood samples over time and at elevated temperatures.

Indexed as

alphavirusdiagnosticsnanoparticlesnanotrap particlessurveillanceVenezuelan equine encephalitis virus

Identifiers

PMID32064269
PMCPMC6999085
OpenAlexW2996833933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.